Genographic Project Releases First DNA Data



The Genographic Project – a $40-million collaboration between IBM, the National Geographic Society, and the Waitt Family Foundation -- has released the first results from the voluntary genealogical DNA analysis program started in 2005. The findings are published in the open access journal PLoS Genetics.

The Genographic Project is using DNA markers to address anthropological questions of human ancestry and historical migration. The goal, says IBM Research scientist Saharon Rosset, is to build an ancient and global family tree using mitochondrial DNA markers to trace female migration, and Y chromosome markers for male history.

Since its inception, the project has collected samples from over 78,000 volunteers. More than 21,000 participants agreed to share their data for public research.

Rosset, a mathematician in Knowledge Discovery & Data Mining at IBM Research, has been involved in addressing statistical analysis and modeling issues for the project. “The overall objective,” he told Bio-IT World, “is learning about history through genetics -- learning about the history of our species, learning about the history of how we populated the globe, how we interacted with each other over time, and the family relationship between all humans around the globe.”

After volunteers submit buccal swabs (DNA participation kits cost $99), participants can look up their results, stored a securely in the Genographic Project’s database, via a Web portal. Based on each samples’s genetic profile -- either from mitochondrial DNA or Y chromosome markers -- researchers can place it in a haplogroup, which defines genetic populations. “It tells [participants] about their ancient ancestry,” says Rosset. “Sort of where you fit on the family tree of all humans.”

The database is heavily biased towards first-world countries in which the project is well publicized and swab kits are generally affordable. So far, 95 percent of the DNA kits were ordered in the United States and Western Europe. Not surprisingly, the majority of the participants are of West Eurasian, probably European, ancestry.

To balance that trend, the Project has also set up 10 laboratories around the world staffed with local scientists to reach people in less developed, more remote regions. “Scientists in research centers around the world are going out and sampling populations, mainly indigenous populations,” says Rosset. “We’re actually going out and focusing on populations that are of great interest in terms of the genetic diversity of the world.”

The Story So Far
Rosset says the most exciting thing about the study so far is sharing so much data with scientists around the world. “We’re giving [this database] back out to the public,” says Rosset. “Everyone who opted in filled out an anonymous questionnaire about ethnic origins, so you have some information that goes together with the genetic sample…. This is really an open project, and the openness and the intent to share both the results we collect and the data we collect with the public and scientific communities [is significant.]”

Rosset points out that even individuals who have gathered genetic information from private companies can use the database. There’s an online tool to import results from other tests and compare their results with participants from the Genographic Project study.

Thanks to IBM’s involvement in building an IT infrastructure to handle the data analysis, including a specialized LIMS, Rosset says that the Project has “normalized the nomenclature and the way in which you do genetic testing on individuals to learn about ancient ancestry.” The PLoS Genetics paper “offers a brand new analytical approach, which is more accurate than all the previously published approaches,” he says. 

Already scientists are searching and using the new data. One of the first searches looks for traces of Neanderthal DNA in the samples. “The question is, ‘Did modern humans mix or interbreed with Neanderthals as they were populating Europe 30 to 40 thousand years ago?’ ” says Rosset.

Six Neanderthal DNA samples longer than 300 base pairs were available in GenBank, which include five mutations believed to distinguish Neanderthal sequences. All five mutations are present within the full Genographic database of 78,590 samples. However, no combination of any two of the five appear together in any given sample. In fact, none of the Project’s collected samples are as divergent from one another as the Neanderthal samples.

“There is no evidence of this mixing in the mitochondrial DNA,” Rosset says. “It doesn’t mean categorically that there was no intermixing… but even in our huge database, which is very rich in samples of European origin, we find no evidence of Neanderthal sequence in there.”

This is just the first of many discoveries Rosset expects from the project. “For example, the ancient history of humans in Africa -- our database is already starting to yield interesting answers about how we moved around and interacted with each other. Similar questions exist about North American, and about the effect of ancient empires on the genetic makeup of the world.”

As the database grows, and once the scientist-gathered samples are included, Rosset believes “it’s going to lead to many exciting finding, and the answers to many fundamental questions about the human population of the world.”

Further Reading:
D.M. Behar et al. “The Genographic Project Public Participation Mitochondrial DNA Database.” PLOS Genetics 3(6): e104 doi:10.1371/journal.pgen.0030104.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .